PEBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Peoples Bancorp Inc (PEBO) is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 to invest. The stock has a constructive technical setup and analysts remain positive, but the current price is already near short-term resistance and there is no strong proprietary buy signal today. My direct view is to hold off on buying now and wait for a clearer entry after earnings or a better pullback.
PEBO is in a short-term bullish trend overall because SMA_5 is above SMA_20 and SMA_20 is above SMA_200, which supports an upward structure. MACD histogram is positive at 0.189, though it is contracting, suggesting momentum is still positive but losing some strength. RSI_6 at 67.693 is near overbought/upper-neutral territory, so the stock is not cheap at current levels. Price at 38.705 is sitting just below resistance at R1 38.995 and close to the pivot 37.723, which limits immediate upside. Based on the pattern analysis, there is a near-term chance of a small bounce, but the next week looks weaker than the monthly outlook.
["Piper Sandler raised its price target to $43 from $41 and keeps an Overweight rating.", "Earlier Piper Sandler cited solid Q1 results, stronger net interest margin, and better controlled operating expenses.", "The announced acquisition of CZNL is viewed positively because it adds a high-quality, low-cost deposit base and liquid balance sheet at attractive pricing.", "Technical trend remains bullish with SMA_5 > SMA_20 > SMA_200.", "Monthly pattern analysis suggests 11.19% upside potential over the next month."]
["No AI Stock Picker signal today.", "No SwingMax signal recently.", "RSI is elevated near overbought levels, so upside may be limited near term.", "MACD momentum is positive but contracting.", "Price is close to resistance at 38.995, reducing immediate entry attractiveness.", "There is no significant hedge fund or insider buying trend.", "No recent congress trading data is available.", "Earnings are upcoming on July 21, 2026, so investors may prefer to wait for confirmation from the report."]
No financial snapshot was available due to an error, so there is no usable latest-quarter revenue, EPS, or deposit/loan growth breakdown to assess directly. The only recent financial commentary available is from Piper Sandler, which said Q1 results were solid, helped by stronger net interest margin and well-managed operating expenses, producing 8% PPNR upside. The company reported total assets of $9.6 billion as of March 31, 2026, and the next quarter to watch is Q2 2026, with earnings scheduled for July 21, 2026.
Analyst sentiment is positive overall. Piper Sandler raised the price target twice, most recently to $43 from $41 while maintaining an Overweight rating. Keefe Bruyette also raised its target to $37 from $35, though it kept a Market Perform rating. The Wall Street pros side is bullish on margin improvement, cost discipline, and the CZNL acquisition, while the cautious side is that one major firm still rates it neutral and the current price is already near resistance.
